BRNS

Barinthus Biotherapeutics

16 hedge funds and large institutions have $10.3M invested in Barinthus Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$8.7K
2 +$974

Top Sellers

1 -$646K
2 -$34.1K
3 -$12.4K
4
BlackRock
BlackRock
New York
-$7.72K
5
IIM
Ipswich Investment Management
Massachusetts
-$6.04K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.2M
2
$1.83M
3
$1.39M
4
$776K
5
$749K
6
$148K
7
$112K
8
$42.4K
9
$21.2K
10
$18K
11
$13.9K
12
$13.2K
13
$12.3K
14
$9.69K
15
$126
16
$72
17
18
19
20